NCT05734482 Pharmacokinetic, Safety and Immunogenicity Study of CMAB015 and Cosentyx in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT05730725 A Study to Evaluate Effectiveness and Safety of BMS-986322 in Participants With Moderate-to-Severe Psoriasis Status COMPLETED Phase PHASE2
NCT05728489 A Study to Test How Well Different Doses of BI 765250 Are Tolerated by People With a Skin Disease Called Plaque Psoriasis Status COMPLETED Phase PHASE1
NCT05725876 Quantitative Fluorescence Molecular Imaging of Ustekinumab-800CW to Elucidate the Drug Distribution Throughout Inflamed Tissue in Crohn's Disease and Psoriasis. Status RECRUITING Phase PHASE1
NCT05725057 Proof of Concept Study of AX-158 in Patients With Mild to Moderate Plaque Psoriasis Status COMPLETED Phase PHASE1/PHASE2
NCT05718921 A Safety, Tolerability and Pharmacokinetics Study of Topical Ointment YR001 in Adult Healthy Volunteers Status COMPLETED Phase PHASE1
NCT05706870 Phase II Study Evaluating the Clinical Efficacy and Safety of GN-037 in Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT05701995 A Study to Evaluate the Effect of Deucravacitinib on Quality of Life in Participants With Plaque Psoriasis in a Community Setting Status COMPLETED Phase PHASE4
NCT05683054 A Non-inferiority Study on Dose Reduction of Adalimumab in Psoriasis Patients Who Are Overtreated Status COMPLETED Phase PHASE4
NCT05680740 A Study to Investigate Efficacy and Safety of VTAMA (Tapinarof) Cream, 1% in Intertriginous Plaque Psoriasis Status COMPLETED Phase PHASE4
NCT05655299 VTX958 Versus Placebo for the Treatment of Moderate to Severe Psoriasis Status TERMINATED Phase PHASE2
NCT05645627 A Study to Evaluate IBI112 in the Treatment of Psoriasis With Moderate to Severe Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT05642182 Study of SFA002 in Patients with Mild to Moderate Psoriasis Plaques Status RECRUITING Phase PHASE1
NCT05636839 UVB-induced Treg Cells Exert Antigen-specific Suppression Through LAG-3 Status RECRUITING Phase NA
NCT05635266 Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives Status RECRUITING Phase N/A
NCT05633264 A Study to Assess Deucravacitinib Post-marketing Surveillance in Participants With Psoriasis in Japan Status COMPLETED Phase N/A
NCT05632042 Response of Metabolic Syndrome and Sexual Dysfunction to Lifestyle Changes in Men With Psoriasis Status UNKNOWN Phase NA